Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
About
About the Journal
Privacy Statement
Open access policy
Contact
Current
Archives
Editorial Board
Procedure for consideration and publication of materials
Guides for authors
Cost of publication
Archive 2018-2006
Search
Login
Home
/
Archives
/
Vol. 41 No. 1 (2019): Experimental Oncology
Vol. 41 No. 1 (2019): Experimental Oncology
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1
Published:
08.06.2023
Editorial
Experimental Oncology — 40 years
2
PDF
Minireview
Quinazoline compounds for antitumor treatment
G.I. Solyanik
3-6
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12414
Original contributions
Evaluation of dose calculation algorithms using different density materials for in-field and out-of-field conditions
S. Alghamdi, A. Tajaldeen
46-52
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12529
Expression profiling of plac1 in murine cancer cell lines
J. Mahmoudian, R. Ghods, M. Nazari, M. Jeddi-Tehrani, M.H. Ghahremani, S.N. Ostad, A.H. Zarnani
7-13
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12743
Integral characteristic of the immune system state predicts breast cancer outcome
M. Stakheyeva, D. Eidenzon, E. Slonimskaya, M. Patysheva, I. Bogdashin, E. Kolegova, E. Grigoriev, E. Choinzonov, N. Cherdyntseva
32-38
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12593
The influence of lactoferrin on elemental homeostasis and activity of metal-containing enzymes in rats with Walker-256 carcinosarcoma
Yu.V. Lozovska, I.M. Andrusishina, N.Yu. Lukianova, A.P. Burlaka, L.A. Naleskina, I.N. Todor, V.F. Chekhun
20-25
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12471
Analysis of LPL gene expression in patients with chronic lymphocytic leukemia
N. Bilous, I. Abramenko, A. Chumak, I. Dyagil, Z. Martina
39-45
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12391
Copy number alterations and copy-neutral loss of heterozygosity in Ukrainian patients with primary myelofibrosis
L. Poluben, Ch.R. Bryke, Y. Hsu, O. Shumeiko, L. Neumerzhitska, B. Klimuk, L. Rybchenko, S. Klymenko, S.P. Balk, P.G. Fraenkel
53-56
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12540
Radiation research to determine local tumor invasion in patients with cervical cancer
O.A. Bakai, T.S. Golovko, A.V. Ganich, O.N. Gavriluk, A.V. Ashykhmin
57-60
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12596
Time-dependent cytotoxicity of dichloroacetate and metformin against Lewis lung carcinoma
D.L. Kolesnik, O.N. Pyaskovskaya, Yu.R. Yakshibaeva, G.I. Solyanik
14-19
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12432
DNA oxidation in patients with metastastic colorectal cancer: clinical significance of 8-hydroxy-deoxyguanosine as an independent prognostic factor
A.A. Burlaka, A.V. Vovk, A.P. Burlaka, O.O. Kolesnik
26-31
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12554
Short communications
Assessment of trace elements in serum of acute lymphoblastic and myeloid leukemia patients
S. Valadbeigi, S. Javadian, M. Ebrahimi-Rad, S. Khatami, R. Saghiri
69-71
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12730
Case report
Cutaneous leiomyosarcoma: a clinical, dermoscopic, pathologic case study
V. De Giorgi, F. Scarfì, F. Silvestri, P. Maida, A. Gori, L. Trane, D. Massi
80-81
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12816
Parathyroid carcinoma: a case report
R. Tkachenko, L. Zakhartseva, A. Golovko, O. Kuryk, G. Lazarenko
72-75
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12775
A case of synchronous bilateral calyx urothelial carcinoma: combined treatment approach
S. Semko, M. Pikul, O. Voylenko, O. Stakhovskyi, O. Kononenko, Yu. Vitruk, E. Stakhovsky
76-79
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12791
Letter to editor
Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia
S.E. Langabeer, K. Haslam, M. Crampe, B. MacDonagh, J. McHugh
82-83
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12685
Information
Tumor and Host: Novel Aspects of Old Problem
87
PDF
Scientific and Practical Conference of Young Scientists “Fundamental Medicine: Integrated Approaches to Cancer Therapy”
O. Brieieva
84-86
PDF
Obituary
Ludmyla Zakharivna Polishchuk (1937–2019)
88
PDF
Hypothesis
Aggregated proteins in malignant and benign neoplasms
D.I. Zabolotnyi, A.A. Belousova, D.D. Zabolotna, T.D. Savchenko, N.M. Voroshylova, M.D. Timchenko, I.R. Tsvirinko, S.V. Verevka
61-68
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-1.12629
Language
Українська
English
Current Issue